Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Aventis describes three novel series of NHE-1 inhibitors

March 4, 2004

Novel 5-HT2A receptor antagonists and their use covered by Biovitrum patent

March 4, 2004

Biovail acquires rights to novel formulations of eprosartan and carvedilol

March 3, 2004

Sanofi-Synthelabo scientists present new vasopressin receptor ligands

March 2, 2004

Milestone achievement in Arena and Merck GPCR collaboration

March 1, 2004

Clinical benefits associated with sitaxsentan in PAH

March 1, 2004

Toll-like receptor 4 involved in outward arterial remodeling in vivo

March 1, 2004

New chymase inhibitors and their use in hypertension, heart failure, etc.

Feb. 27, 2004

Novel antihypertensive agents discovered by French researchers

Feb. 27, 2004

Guidant and Cordis to copromote Cypher stent in U.S.

Feb. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...